October 2020 - Volume 27 - Issue 10 - Contributor Index

Alphabetical Search
I
O
Q
V

A proprotein convertase subtilisin/kexin type 9 inhibitor provides comparable efficacy with lower detriment than statins on mitochondria of oxidative muscle of obese estrogen-deprived rats

Thonusin, Chanisa; Pantiya, Patcharapong; Jaiwongkam, Thidarat; More

Menopause. 27(10):1155-1166, October 2020.

A proprotein convertase subtilisin/kexin type 9 inhibitor provides comparable efficacy with lower detriment than statins on mitochondria of oxidative muscle of obese estrogen-deprived rats

Thonusin, Chanisa; Pantiya, Patcharapong; Jaiwongkam, Thidarat; More

Menopause. 27(10):1155-1166, October 2020.

The association between weight-promoting medication use and weight gain in postmenopausal women: findings from the Women's Health Initiative

Stanford, Fatima Cody; Cena, Hellas; Biino, Ginevra; More

Menopause. 27(10):1117-1125, October 2020.

The association between weight-promoting medication use and weight gain in postmenopausal women: findings from the Women's Health Initiative

Stanford, Fatima Cody; Cena, Hellas; Biino, Ginevra; More

Menopause. 27(10):1117-1125, October 2020.

Author:
Cena, Hellas MD

The association between weight-promoting medication use and weight gain in postmenopausal women: findings from the Women's Health Initiative

Stanford, Fatima Cody; Cena, Hellas; Biino, Ginevra; More

Menopause. 27(10):1117-1125, October 2020.

A proprotein convertase subtilisin/kexin type 9 inhibitor provides comparable efficacy with lower detriment than statins on mitochondria of oxidative muscle of obese estrogen-deprived rats

Thonusin, Chanisa; Pantiya, Patcharapong; Jaiwongkam, Thidarat; More

Menopause. 27(10):1155-1166, October 2020.

A proprotein convertase subtilisin/kexin type 9 inhibitor provides comparable efficacy with lower detriment than statins on mitochondria of oxidative muscle of obese estrogen-deprived rats

Thonusin, Chanisa; Pantiya, Patcharapong; Jaiwongkam, Thidarat; More

Menopause. 27(10):1155-1166, October 2020.

Author:
Deal, Chad MD

The association between weight-promoting medication use and weight gain in postmenopausal women: findings from the Women's Health Initiative

Stanford, Fatima Cody; Cena, Hellas; Biino, Ginevra; More

Menopause. 27(10):1117-1125, October 2020.

Author:
Hu, Junping BSN
Author:
Hui, Yujie MM

A proprotein convertase subtilisin/kexin type 9 inhibitor provides comparable efficacy with lower detriment than statins on mitochondria of oxidative muscle of obese estrogen-deprived rats

Thonusin, Chanisa; Pantiya, Patcharapong; Jaiwongkam, Thidarat; More

Menopause. 27(10):1155-1166, October 2020.

The association between weight-promoting medication use and weight gain in postmenopausal women: findings from the Women's Health Initiative

Stanford, Fatima Cody; Cena, Hellas; Biino, Ginevra; More

Menopause. 27(10):1117-1125, October 2020.

Author:
Kang, Jia PhD

A proprotein convertase subtilisin/kexin type 9 inhibitor provides comparable efficacy with lower detriment than statins on mitochondria of oxidative muscle of obese estrogen-deprived rats

Thonusin, Chanisa; Pantiya, Patcharapong; Jaiwongkam, Thidarat; More

Menopause. 27(10):1155-1166, October 2020.

Author:
Lee, Seonah BS
Author:
Liang, Shuo MD
Author:
Ma, Yidi PhD

The association between weight-promoting medication use and weight gain in postmenopausal women: findings from the Women's Health Initiative

Stanford, Fatima Cody; Cena, Hellas; Biino, Ginevra; More

Menopause. 27(10):1117-1125, October 2020.

A proprotein convertase subtilisin/kexin type 9 inhibitor provides comparable efficacy with lower detriment than statins on mitochondria of oxidative muscle of obese estrogen-deprived rats

Thonusin, Chanisa; Pantiya, Patcharapong; Jaiwongkam, Thidarat; More

Menopause. 27(10):1155-1166, October 2020.

A proprotein convertase subtilisin/kexin type 9 inhibitor provides comparable efficacy with lower detriment than statins on mitochondria of oxidative muscle of obese estrogen-deprived rats

Thonusin, Chanisa; Pantiya, Patcharapong; Jaiwongkam, Thidarat; More

Menopause. 27(10):1155-1166, October 2020.

A proprotein convertase subtilisin/kexin type 9 inhibitor provides comparable efficacy with lower detriment than statins on mitochondria of oxidative muscle of obese estrogen-deprived rats

Thonusin, Chanisa; Pantiya, Patcharapong; Jaiwongkam, Thidarat; More

Menopause. 27(10):1155-1166, October 2020.

The association between weight-promoting medication use and weight gain in postmenopausal women: findings from the Women's Health Initiative

Stanford, Fatima Cody; Cena, Hellas; Biino, Ginevra; More

Menopause. 27(10):1117-1125, October 2020.

The association between weight-promoting medication use and weight gain in postmenopausal women: findings from the Women's Health Initiative

Stanford, Fatima Cody; Cena, Hellas; Biino, Ginevra; More

Menopause. 27(10):1117-1125, October 2020.

A proprotein convertase subtilisin/kexin type 9 inhibitor provides comparable efficacy with lower detriment than statins on mitochondria of oxidative muscle of obese estrogen-deprived rats

Thonusin, Chanisa; Pantiya, Patcharapong; Jaiwongkam, Thidarat; More

Menopause. 27(10):1155-1166, October 2020.

The association between weight-promoting medication use and weight gain in postmenopausal women: findings from the Women's Health Initiative

Stanford, Fatima Cody; Cena, Hellas; Biino, Ginevra; More

Menopause. 27(10):1117-1125, October 2020.

Author:
Wang, Yamei PhD
Author:
Wang, Yuhong MM

The association between weight-promoting medication use and weight gain in postmenopausal women: findings from the Women's Health Initiative

Stanford, Fatima Cody; Cena, Hellas; Biino, Ginevra; More

Menopause. 27(10):1117-1125, October 2020.

The association between weight-promoting medication use and weight gain in postmenopausal women: findings from the Women's Health Initiative

Stanford, Fatima Cody; Cena, Hellas; Biino, Ginevra; More

Menopause. 27(10):1117-1125, October 2020.

Author:
Xu, Tao PhD
Author:
Zhang, Jing BSN
Author:
Zhang, Ye PhD
Author:
Zhu, Lan MD
Show: